|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | ||
| Non-cash share-based compensation | ||
| Accretion on marketable securities | ||
| Deferred taxes | ||
| Unrealized foreign exchange gains | ||
| Realized investment gains | ||
| Changes in operating assets and liabilities: | ||
| Research and development tax credit receivable | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Accrued expenses and other liabilities | ||
| Net cash used in operating activities | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Investments marketable securities | ||
| Proceeds from maturities of marketable securities | ||
| Purchases of property and equipment | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds of issuance of ordinary shares, net of issuance costs | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net increase (decrease) in cash and cash equivalents | ||
| Cash and cash equivalents, beginning of period | ||
| Cash and cash equivalents, end of period | ||
| Net cash provided by financing activities | ||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash, beginning of period | ||
| Cash, cash equivalents and restricted cash, end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Cash paid for income taxes |
Loading...
